- Salesforce (CRM, Financial) partners with Takeda to enhance AI-driven customer engagement in the life sciences sector.
- Takeda will use Salesforce's Life Sciences Cloud, adopting AI tools for improved interactions with healthcare professionals.
- This collaboration marks Takeda's influence on Salesforce's AI-powered platform development for the industry.
Salesforce (CRM), a leader in AI-powered customer relationship management, has announced a strategic collaboration with Takeda, a global pharmaceutical company. This partnership will see Takeda adopt Salesforce's Life Sciences Cloud for Customer Engagement to enhance its communications with healthcare professionals.
The integration will feature real-time insights and intelligent analytics directly embedded into Takeda's workflows, allowing for more efficient and personalized interactions. This initiative will encompass operations ranging from medical to commercial and patient support, utilizing Salesforce’s comprehensive platform, including Agentforce and Data Cloud.
Frank Defesche, Senior Vice President and General Manager of Life Sciences at Salesforce, emphasized the significance of this collaboration, stating, "Takeda is an outstanding leader in the industry, aspiring to create better health for people and a brighter future for the world. Now, with Life Sciences Cloud for Customer Engagement, we'll help Takeda improve provider and patient engagement and scale the impact of every team member."
This engagement positions Takeda as an early adopter, allowing the company to influence the ongoing development of Salesforce’s industry-specific platform. The partnership contributes to Salesforce's expanding presence in the pharmaceutical and biotech sectors as more companies leverage AI solutions to unify data and improve engagement across their organizations.
